2022 American Transplant Congress
Combined CyTOF and Elispot Investigation of CMV Response Over the First Year Post Kidney Transplantation
*Purpose: CMV remains a threat for kidney transplant recipients (KTR). Deciphering the impact of CMV on the immune system of KTR has helped improving CMV…2022 American Transplant Congress
Long Term Analysis of Pediatric En-Bloc Kidney Transplantation: A Single Center Experience
*Purpose: Pediatric en-bloc kidney transplantations for adult recipients are uncommonly performed due to unique donor characteristics, the technical challenge of the operation, and potential surgical…2022 American Transplant Congress
Kidney Transplantation in Patients Postradical Prostatectomy
Temple University Hospital, Philadelphia, PA
*Purpose: The population of the United States is aging. By the year 2050 those over 65 years of age are projected to make up 20.2%…2022 American Transplant Congress
Exploring the Differential Access Hypothesis: Do Black Kidney Transplant Candidates Have Less Social Network Access to Potential Living Donors Than White Candidates?
*Purpose: This study assesses the ‘differential access’ hypothesis that non-Hispanic Black kidney transplant candidates in the United States have access to fewer healthy, willing potential…2022 American Transplant Congress
Association of Native Kidney Disease with De Novo Cancer Development After Kidney Transplant
*Purpose: Primary glomerulonephritis (GN) and congenital anomalies of the kidney and urinary tract (CAKUT) have been shown to be associated with cancer development in the…2022 American Transplant Congress
Barriers and Facilitators to Care for Patients with Failed Kidney Transplants
*Purpose: To understand the barriers and facilitators to care for patients with failed kidney transplants from the perspective of providers.*Methods: Qualitative study employed focus groups…2022 American Transplant Congress
Semaglutide Tolerability and Efficacy in Patients with Chronic Kidney Disease Stage 4, 5 and End Stage Renal Disease
*Purpose: Obesity is often a barrier to kidney transplantation (KT) due to increased perioperative risks and worse outcomes with many transplant centers setting BMI cut…2022 American Transplant Congress
Low-Dose Aspirin is Effective in Preventing Transplant Renal Artery Stenosis: A Prospective Randomized Controlled Trial
Henan Provincial People's Hospital, Zhengzhou, Henan Province, China
*Purpose: Transplant renal artery stenosis (TRAS), the most common post-transplant vascular complication, leads to resistant hypertension, renal impairment, and even graft loss. No effective prophylactic…2022 American Transplant Congress
Can We Predict Progression of Potential Donation After Cardiac Death Donors (DCD) Using DonorNet?
*Purpose: DCD utilization of livers is limited by unpredictability of progression, perceived worse outcome, and costs related to deployment of resources. We aimed to predict…2022 American Transplant Congress
Long-Term Rejection Free Renal Allograft Survival with Fc-Modified Anti-cd154 Antibody Monotherapy in Nonhuman Primates
MGH Center for Transplantation Sciences, Boston, MA
*Purpose: Belatacept is currently the only FDA approved costimulatory blockade (CB) used as an alternative to calcineurin inhibitors in kidney transplantation. However, it has been…
- « Previous Page
- 1
- …
- 119
- 120
- 121
- 122
- 123
- …
- 1683
- Next Page »